Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901238 · ClinicalTrials.gov registry record · Phase 1
Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT00901238 is a Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 100 participants.
The verdict
NCT00901238, a Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
Conventional treatments of retinoblastoma involves laser photocoagulation, cryotherapy (freezing of the tumor), plaque radiotherapy,external beam radiotherapy, and intravenous chemotherapy. Enucleation (removing of the eye)is the last option when the tumor cannot be controlled otherwise. However,many children with retinoblastoma present with advanced intraocular disease for which enucleation is the only option. Intra-arterial chemotherapy (Chemosurgery)delivers anti-tumor drug directly into the ophthalmic artery (the artery feeding the eye) in order to increase the dose of drug reaching the tumor while minimizing toxicity to the rest of the body.
Interventions
- PROCEDURE Intra-arterial Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00901238
The ClinicalTrials.gov registry entry for NCT00901238 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intra-arterial Chemotherapy is the first listed.
NCT00901238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00901238 about?
NCT00901238 is a clinical study titled "Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma". Conventional treatments of retinoblastoma involves laser photocoagulation, cryotherapy (freezing of the tumor), plaque radiotherapy,external beam radiotherapy, and intravenous chemotherapy. Enucleation (removing of the eye)is the last option when the tumor cannot be controlled otherwise. However,man...
What is the current status of trial NCT00901238?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2006-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00901238?
The interventions under investigation include: Intra-arterial Chemotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT00901238?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.